HVIVO touts positive test results from seasonal flu drug, CD388
HVIVO PLC on Monday said that Cidara Therapeutics Inc has seen positive results from an ongoing study testing CD388, a drug designed to treat seasonal flu. hVIVO is a London-based specialist... | April 3, 2023
Source: marketscreener.com